Latest Market News

Emerald Resources has cleared the final regulatory hurdle for its Dingo Range Gold Project and committed A$30 million to critical equipment purchases, underpinning its ambition to become a multi-mine gold producer across Australia and Cambodia.

Aurizon reports volume growth across coal, bulk, and container freight for ten months to April, maintaining FY2026 EBITDA and dividend guidance amid a temporary $10 million fuel cost timing hit.

Acusensus Limited maintains its FY26 revenue and EBITDA guidance while advancing multiple enforcement programs across the US, UK, New Zealand, and Australia, underpinned by new product developments and international growth.

Advance Metals has launched its first diamond drilling campaign at the high-grade Gavilanes Silver Project in Mexico, aiming to convert a substantial Foreign Estimate into a JORC-compliant resource by year-end.

Celsius Resources faces a setback as interim legal orders to block Sodor’s control over Makilala Mining are denied, with recent shareholder meetings reshaping the board despite expired payment deadlines.

West Coast Silver (ASX:WCE) has unveiled a comprehensive Growth & Development Plan for its Elizabeth Hill Silver Project, targeting a rapid transition to production via a high-grade, low-capex open pit operation supported by ongoing drilling and resource expansion.

Genesis Minerals is poised to boost its gold output to an aspirational 500,000 ounces per annum following its strategic acquisition of Magnetic Resources and the construction of a new Tower Hill mill in Western Australia.

IMDEX Limited has delivered a record 3Q FY26 revenue increase of 29% in constant currency, fueled by strong global demand, strategic acquisitions, and AI-enabled mining technology solutions.

Dreadnought Resources has launched a comprehensive target definition program at its Mangaroon Gold Project, deploying soil sampling and a gradient array induced polarization survey to pinpoint new drill targets ahead of discovery-focused drilling later this year.

Noxopharm is gearing up for a pivotal pre-IND meeting with the US FDA, enlisting global CRO Novotech to sharpen its regulatory approach for SOF-SKN, a drug targeting autoimmune skin diseases.

Regal Partners showcased its diversified $21 billion funds under management and ongoing growth momentum at the Macquarie Australia Conference, emphasising strong inflows, product innovation, and offshore expansion.

Channel Infrastructure NZ Limited has accelerated key project completions and expanded contract scope, prompting a raised EBITDA forecast for FY2026 amid an uncertain fuel demand outlook.